<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01887769</url>
  </required_header>
  <id_info>
    <org_study_id>20824</org_study_id>
    <nct_id>NCT01887769</nct_id>
  </id_info>
  <brief_title>Body Composition Analysis for Patient With Lung Cancer Using Computed Tomography Image Analysis</brief_title>
  <acronym>BAT-SCAN</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: With 1.6 million new cases diagnosed each year and 1.3 million deaths, lung cancer
      is the leading cancer-related death worldwide and it represents a pressing health issue.
      Patients with lung cancer are more likely to experience cachexia, a severe debilitating
      disorder causing fatigue, weight loss, muscle wasting and associated with reduced physical
      function, increased chemotherapy toxicity and reduced survival. This syndrome occurring in
      about 80% of advanced cancer patients is the direct cause of death in about 20% of cases.
      However, despite the importance of cachexia in lung cancer, it has been mainly studied from
      several assessment methods which do not usually differentiate muscle from other tissues.

      Aim: To analyze body composition of patients with lung cancer at diagnosis using computed
      tomography (CT-Scan) image analysis.

      Methods: This is a retrospective study extending over a period of 3 years conducted at the
      Institut universitaire de cardiologie et de pneumologie de Québec (2009-2012). We listed
      patients newly diagnosed with lung cancer who had a thoraco-abdominal CT-scan performed in
      our institution. Following the collection of clinical data from patient records, we used
      SliceOmatic software to quantify muscle area, visceral fat area and subcutaneous fat area
      from a single abdominal cross-sectional image at the level of the third lumbar vertebra.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of muscle area (cm2/m2) at the level of the third lumbar vertebra</measure>
    <time_frame>at the time of the diagnosis of lung cancer and one year following it.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of fat area (cm2/m2) at the level of the third lumbar vertebra</measure>
    <time_frame>at the time of the diagnosis of lung cancer and one year following it.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>days of survival</measure>
    <time_frame>From the time of the diagnosis of lung cancer until one year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Lung cancer patient at diagnosis</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Lung cancer patients, at diagnosis, following in oncology clinic
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men or women

          -  Between 40-80 years of age

          -  Primary lung cancer diagnosed between 2009 and 2012

          -  CT-Scan done at the time of the diagnosis

        Exclusion Criteria:

          -  Chemotherapy, radiotherapy or surgery at the time of the first Ct-Scan image

          -  History of other cancer (during the last five years)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Didier Saey, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut universitaire de cardiologie et de pneumologie de Québec</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier Saey, PhD</last_name>
      <phone>418-656-8711</phone>
      <phone_ext>2614</phone_ext>
      <email>didier.saey@criucpq.ulaval.ca</email>
    </contact>
    <investigator>
      <last_name>Didier Saey, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2013</study_first_submitted>
  <study_first_submitted_qc>June 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2013</study_first_posted>
  <last_update_submitted>January 5, 2017</last_update_submitted>
  <last_update_submitted_qc>January 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec</investigator_affiliation>
    <investigator_full_name>Didier Saey</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Lung cancer</keyword>
  <keyword>Body composition analysis</keyword>
  <keyword>Ct-Scan</keyword>
  <keyword>Muscle mass</keyword>
  <keyword>Cachexia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

